Navigation Links
YM BIOSCIENCES REPORTS FISCAL FIRST QUARTER 2010 OPERATIONAL AND FINANCIAL RESULTS
Date:11/11/2009

------------ (2,581,353) (3,334,401) Financing activities: Issue of common shares on exercise of options 11,424 - Investing activities: Short-term deposits, net 34,504,869 13,200,126 Additions to property and equipment (3,563) (12,704) ----------------------------------------------------------------------- 34,501,306 13,187,422 ------------------------------------------------------------------------- Increase in cash 31,931,377 9,853,021 Cash, beginning of period 2,337,716 3,119,189 ------------------------------------------------------------------------- Cash, end of period $ 34,269,093 $ 12,972,210 ------------------------------------------------------------------------- -------------------------------------------------------------------------

SOURCE YM BioSciences Inc.


'/>"/>
SOURCE YM BioSciences Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related biology technology :

1. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
2. Selection of Development Candidate Triggers $0.5 Million Milestone Payment to Ardea Biosciences, Inc.
3. ImmuneRegen BioSciences Files 8-K that Highlights Enclosed Shareholder Letter Discussing Recent Achievements and Outlook
4. ONCOSCIENCE AG, THE EUROPEAN PARTNER OF YM BIOSCIENCES, ANNOUNCES COMPLETION OF PATIENT ENROLLMENT IN PHASE III BRAIN CANCER TRIAL OF NIMOTUZUMAB
5. Pressure BioSciences, Inc. Reports Second Quarter 2007 Financial Results and Provides Business Update
6. YM BIOSCIENCES, EUROPEAN PARTNER, ONCOSCIENCE AG, ANNOUNCES INITIATION OF ADVANCED NIMOTUZUMAB TRIALS IN ADULT GLIOMA AND PANCREATIC CANCER
7. Monogram Biosciences to Present at the Thomas Weisel Partners Healthcare Conference 2007
8. Magellan Biosciences Names Steven E. Diamond, PhD, Chief Scientific Officer
9. Pressure BioSciences, Inc. Issued First Patent in Canada
10. Neurocrine Biosciences to Present at the BioCentury: Newsmakers in the Biotech Industry Conference
11. YM BioSciences USA cleared by US FDA to initiate Phase II clinical trial of nimotuzumab in children with inoperable, recurrent brain cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/3/2015)... 3, 2015 ... dass das US-amerikanische Patent- und Markenamt ... das den Schutz des geistigen Eigentums ... Zellwand-Nukleinsäurekomplex (MCNA) von Telesta bietet.  MCNA ... im Spätstadium entwickelt für die Behandlung ...
(Date:6/3/2015)... Yonkers, NY (PRWEB) June 03, 2015 ... GRAPHALLOY ® bushing materials, will be an exhibitor at ... show runs from June 15 – June 19 and ... engineering and the process industry. , Graphite Metallizing ... will be discussing two exciting new business initiatives. The ...
(Date:6/3/2015)... June 3, 2015  Bone morphogenetic proteins (BMP) are ... in 1965 by Marshall Urist , bone morphogenetic ... induce mesenchymal stem cells to differentiate into osteoblast cells. ... date; only BMP 2, 7 and 9 have osteoinductive ... role in bone formation. However, of these, only BMP-2 ...
(Date:6/3/2015)... , June 3, 2015  inVentiv ... development and comprehensive commercialization services, today announced ... as President, inVentiv Health Clinical Division and ... is a seasoned veteran within the CRO ... clinical development, technology and the development of ...
Breaking Biology Technology:Telesta Therapeutics gibt Erteilung des MCNA-Stoffpatents durch das US-amerikanische Patent- und Markenamt bekannt 2Telesta Therapeutics gibt Erteilung des MCNA-Stoffpatents durch das US-amerikanische Patent- und Markenamt bekannt 3GRAPHALLOY Exhibiting at the 2015 ACHEMA World Forum 2Bone Morphogenetic Proteins Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2014 - 2022 2Bone Morphogenetic Proteins Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2014 - 2022 3inVentiv Health Names Dr. Michael McKelvey President, Clinical Division And Executive Vice President, inVentiv Health 2inVentiv Health Names Dr. Michael McKelvey President, Clinical Division And Executive Vice President, inVentiv Health 3inVentiv Health Names Dr. Michael McKelvey President, Clinical Division And Executive Vice President, inVentiv Health 4inVentiv Health Names Dr. Michael McKelvey President, Clinical Division And Executive Vice President, inVentiv Health 5
... ... Spectroscopy Data , ... (PRWEB) February 19, 2010 -- Photometrics , a designer and manufacturer of high-performance ... 2010 Biophysical Annual Meeting. The presentations will cover technologies in the Evolve camera ...
... , ATLANTA , Feb. 18 ... (the "Company"), an Atlanta -based, biopharmaceutical company developing vaccines ... that it presented the results of a preclinical study on ... and Opportunistic Infections (CROI) in San Francisco . ...
... , BOSTON , Feb. 18 ... Dermal Repair Scaffold has been awarded the coveted American ... is a bioactive collagen matrix used in the management of ... wounds. , APMA is the nation,s leading professional society ...
Cached Biology Technology:Photometrics to Offer Presentations on EMCCD Bio-Imaging Advances at 2010 Biophysical Annual Meeting 2Photometrics to Offer Presentations on EMCCD Bio-Imaging Advances at 2010 Biophysical Annual Meeting 3Photometrics to Offer Presentations on EMCCD Bio-Imaging Advances at 2010 Biophysical Annual Meeting 4GeoVax Labs, Inc. Reports Data on Prototype Adjuvant - Supplemented HIV Vaccine Tested in Preclinical Animal Studies 2GeoVax Labs, Inc. Reports Data on Prototype Adjuvant - Supplemented HIV Vaccine Tested in Preclinical Animal Studies 3GeoVax Labs, Inc. Reports Data on Prototype Adjuvant - Supplemented HIV Vaccine Tested in Preclinical Animal Studies 4GeoVax Labs, Inc. Reports Data on Prototype Adjuvant - Supplemented HIV Vaccine Tested in Preclinical Animal Studies 5GeoVax Labs, Inc. Reports Data on Prototype Adjuvant - Supplemented HIV Vaccine Tested in Preclinical Animal Studies 6TEI Biosciences' PriMatrix(TM) Awarded Seal of Approval by American Podiatric Medical Association 2TEI Biosciences' PriMatrix(TM) Awarded Seal of Approval by American Podiatric Medical Association 3
(Date:6/1/2015)... , June 1, 2015 According ... Touchless Sensing Market by Technology (Touch-based & Touchless), Application ... Equipment), & by Geography - Global Forecast to 2020", ... Market is expected to reach $23.55 Billion by 2020, ... Browse 83 market data T ...
(Date:6/1/2015)... June 1, 2015 According ... Biometrics Market by Application (Government, Military & Defense, ... Immigration, and Security), Technology (Face Recognition, Fingerprint Recognition, ... Vein Recognition, and Others), Function (Contact and Non-Contact) ... Europe , APAC, Row) - ...
(Date:5/29/2015)... DUBLIN , May 28, 2015 ... the addition of the "Facial Recognition Market ... User - Global Forecast to 2020" report ... years, have seen facial recognition technology become more ... technology to gain traction and investment from the ...
Breaking Biology News(10 mins):Gesture Recognition & Touchless Sensing Market Worth $23.55 Billion by 2020 2Gesture Recognition & Touchless Sensing Market Worth $23.55 Billion by 2020 3Gesture Recognition & Touchless Sensing Market Worth $23.55 Billion by 2020 4Next Generation Biometrics Market Worth $24,448.84 Million by 2020 2Next Generation Biometrics Market Worth $24,448.84 Million by 2020 3Next Generation Biometrics Market Worth $24,448.84 Million by 2020 4Global advanced Facial Recognition Market Expected to Grow From $2.77 Billion in 2015 to $6.19 Billion in 2020, at an Estimated CAGR of 17.4% 2
... The lowly appendix, long-regarded as a useless evolutionary artifact, won ... Medical Center proposed that it actually serves a critical function. ... bacteria could hang out until they were needed to repopulate ... Now, some of those same researchers are ...
... new study finds that young muskoxen conserve heat almost as ... longstanding assumption among scientists that young animals should be more ... from the University of Sydney, Australia, will be published in ... Surviving freezing winters is tough for any animal, but ...
... the chain of events that gives stem cells their remarkable ... Stem Cell Research at the University of Cambridge have pinpointed ... stem cells their unique ability to develop into any of ... cells to skin cells). Their findings, published today in the ...
Cached Biology News:Evolution of the appendix: A biological 'remnant' no more 2Evolution of the appendix: A biological 'remnant' no more 3Study: Young Arctic muskoxen better at keeping warm than scientists thought 2Switching on the power of stem cells 2
... 50 X-Ray System from KUBTEC is a dual ... and three dimensional representation of the specimen under ... of specimen X-ray images, the micro focus source ... of detail in standard 2D images. The 50 ...
... BTX, the leader in electroporation products and ... innovative product line for experiment optimization and ... is a breakthrough in Molecular Delivery. The ... procedures that typically limited the number of ...
... PolarScreen Progesterone Receptor (PR) Competitor Assay ... screening novel progesterone receptor binding compounds ... assay utilizes a fusion of glutathione ... of human progesterone receptor [PR-LBD(GST)] and ...
... Molecular Imaging Systems group announces the ... Digital Imaging Systems, featuring high resolution ... fluorescence, luminescence, radiographic and chromogenic imaging ... CCD and 10x optical zoom lens ...
Biology Products: